Drugs Containing Excipient (Inactive Ingredient) ACETYL TETRAPEPTIDE-3

Generic drugs containing ACETYL TETRAPEPTIDE-3 excipient

Company	Ingredient	NDC	Excipient
Consilii LLC	5% minoxidil hair growth oil	83299-017	ACETYL TETRAPEPTIDE-3

ACETYL TETRAPEPTIDE-3: Market Dynamics and Financial Trajectory

Last updated: February 19, 2026

This report analyzes the market dynamics and financial trajectory of Acetyl Tetrapeptide-3, a synthetic peptide primarily utilized as a pharmaceutical excipient. The analysis focuses on its application in hair growth and eyelash enhancement products, patent landscape, key market players, and projected financial performance.

What is Acetyl Tetrapeptide-3?

Acetyl Tetrapeptide-3 is a biomimetic peptide composed of four amino acids. Its chemical structure is Ac-Gly-His-Lys-Ser-OH. The peptide is designed to mimic the natural signaling molecules involved in hair follicle regeneration and strengthening. Its primary mechanism of action involves stimulating the proliferation of dermal papilla cells, which are crucial for hair follicle development and growth. This stimulation leads to improved blood circulation in the scalp, enhanced nutrient delivery to the hair follicles, and increased anchoring of hair fibers to the dermal papilla.

The peptide is typically synthesized through solid-phase peptide synthesis. Purity is a critical quality attribute, with pharmaceutical-grade materials requiring >95% purity, often >98%, verified by High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS). Stability studies are essential, with typical shelf-life requirements of 2-3 years when stored under recommended conditions (e.g., 2-8°C, protected from light).

How is Acetyl Tetrapeptide-3 Used in Pharmaceuticals?

The primary pharmaceutical application of Acetyl Tetrapeptide-3 is as an active ingredient or a key functional excipient in topical formulations targeting hair loss and thinning, and for enhancing eyelash and eyebrow growth.

Applications:

• Hair Growth Formulations: Incorporated into shampoos, conditioners, serums, and topical solutions designed to combat androgenetic alopecia (male and female pattern baldness), telogen effluvium, and other forms of hair loss.
• Eyelash and Eyebrow Enhancers: A common ingredient in serums and treatments aimed at promoting longer, thicker, and fuller eyelashes and eyebrows.
• Dermatological Preparations: Investigated for potential use in wound healing and skin regeneration due to its role in cellular signaling and tissue repair.

Formulations and Delivery:

• Concentration: Typical usage concentrations in finished cosmetic or pharmaceutical products range from 0.001% to 0.01%.
• Solubility: Soluble in water and polar solvents.
• Stability in Formulation: Generally stable in aqueous formulations. pH stability is typically observed in the range of 4.0 to 6.0. Compatibility with other common cosmetic ingredients, such as humectants, emollients, and other peptides, is a key consideration during formulation development.

What is the Patent Landscape for Acetyl Tetrapeptide-3?

The patent landscape for Acetyl Tetrapeptide-3 is characterized by patents covering its synthesis, specific formulations, and methods of use, particularly for hair growth and cosmetic applications.

Key Patent Areas:

• Synthesis Methods: Patents may claim novel or improved processes for synthesizing the peptide, aiming for higher purity, yield, or cost-effectiveness.
• Formulations: A significant portion of patent activity relates to the incorporation of Acetyl Tetrapeptide-3 into specific delivery systems (e.g., liposomes, microemulsions) or combined with other active ingredients to enhance efficacy or stability.
• Methods of Use: Patents may protect the use of Acetyl Tetrapeptide-3 for treating specific hair loss conditions or for achieving particular cosmetic outcomes (e.g., increased hair density, enhanced lash length).

Notable Patent Holders and Their Focus:

While specific patent numbers and detailed claims require proprietary database access, companies involved in cosmetic ingredients and dermatological products are prominent in this space. Examples of entities that have filed patents or hold intellectual property related to this peptide or similar technologies include:

• Sederma (Croda International Plc): Known for its development and commercialization of cosmetic active ingredients. Their "Capixyl™" product is a well-recognized commercial ingredient that includes Acetyl Tetrapeptide-3 along with Trifolium Pratense (Red Clover) Flower Extract. Patents associated with Sederma would likely focus on the synergistic effects of the peptide and botanical extract, as well as specific formulation strategies.
• Laboratoires Vivaltus: This entity has been associated with patents related to cosmetic compositions containing peptides for hair growth.
• Various Cosmetic Ingredient Suppliers: Numerous other chemical manufacturers and suppliers specializing in peptide synthesis for the cosmetic and pharmaceutical industries may hold patents related to production processes or specific compositions.

Patent Expiry and Generic Competition:

The expiration of foundational patents related to the synthesis and basic use of Acetyl Tetrapeptide-3 can open the door for generic ingredient manufacturers. However, patents covering specific synergistic combinations, advanced delivery systems, or novel applications can extend the effective market exclusivity for specific branded products or formulations.

Who are the Key Market Players for Acetyl Tetrapeptide-3?

The market for Acetyl Tetrapeptide-3 involves both manufacturers of the raw peptide and formulators who incorporate it into finished products.

Raw Material Manufacturers and Suppliers:

These companies specialize in the synthesis and purification of Acetyl Tetrapeptide-3, supplying it to cosmetic and pharmaceutical formulators.

• Sederma (Croda International Plc): As mentioned, their commercial ingredient "Capixyl™" is a significant market product. They act as a supplier of this proprietary blend.
• DSM: A global science-based company active in nutrition, health, and bioscience, DSM also offers a range of cosmetic peptides, potentially including or competing with Acetyl Tetrapeptide-3.
• Advanced Peptide Technology: Several specialized peptide synthesis companies globally supply Acetyl Tetrapeptide-3 to the market. These often operate on a B2B model, providing high-purity peptides to formulators.
• Other Chemical Suppliers: A broad spectrum of chemical suppliers, particularly those focusing on cosmetic raw materials, list Acetyl Tetrapeptide-3 in their product portfolios. Due diligence is required to ascertain the quality and regulatory compliance of these suppliers for pharmaceutical-grade materials.

Formulators and Brands:

These companies purchase Acetyl Tetrapeptide-3 (or branded blends containing it) and incorporate it into their finished products.

• Cosmeceutical Brands: Numerous brands in the skincare and haircare markets utilize Acetyl Tetrapeptide-3 in their premium anti-aging and hair-restoration lines. Examples include:
  • Nioxin (Procter & Gamble)
  • Viviscal (Church & Dwight)
  • Regenera Pharma
  • Numerous smaller, independent cosmeceutical brands.
• Pharmaceutical Companies: While primarily used in cosmeceuticals, its investigation for dermatological applications means some pharmaceutical companies may be exploring its use in prescription or over-the-counter topical treatments.

The competitive landscape is segmented between raw material producers, often focused on B2B sales, and end-product brands marketing to consumers. Proprietary blends like Capixyl™ can create a competitive moat for specific suppliers.

What is the Market Size and Financial Trajectory for Acetyl Tetrapeptide-3?

Estimating the precise market size for a specific excipient like Acetyl Tetrapeptide-3 is challenging, as it is often aggregated within broader categories of cosmetic peptides or hair growth ingredients. However, its widespread use in popular consumer products indicates a significant and growing market.

Market Drivers:

• Increasing Prevalence of Hair Loss: Aging populations and changing lifestyle factors contribute to a rising incidence of hair thinning and loss globally, driving demand for effective treatments.
• Consumer Demand for Natural and Science-Backed Ingredients: Acetyl Tetrapeptide-3 benefits from its biomimetic nature and the scientific backing for its efficacy in stimulating hair follicle activity, aligning with consumer preferences.
• Growth of the Cosmeceutical Market: The expanding cosmeceutical sector, which bridges the gap between cosmetics and pharmaceuticals, provides a primary channel for Acetyl Tetrapeptide-3's commercialization.
• E-commerce and Direct-to-Consumer (DTC) Sales: The rise of online retail allows smaller brands to reach consumers directly, increasing market penetration for products containing such specialized ingredients.
• Innovation in Formulation: Development of advanced delivery systems can enhance the efficacy of Acetyl Tetrapeptide-3, further stimulating market demand.

Market Growth Projections:

While specific data for Acetyl Tetrapeptide-3 is not publicly disaggregated, the global cosmetic peptide market is projected for substantial growth.

• Global Cosmetic Peptide Market: This broader market is estimated to be worth billions of dollars and is forecast to grow at a Compound Annual Growth Rate (CAGR) of 6% to 9% over the next five to seven years. (Sources: Market research reports from firms like Grand View Research, Mordor Intelligence).
• Hair Growth Ingredients Market: This segment, where Acetyl Tetrapeptide-3 plays a key role, is also experiencing robust growth, driven by the factors listed above. This sub-segment is expected to see a CAGR of 5% to 7%.

Financial Trajectory Considerations:

• Price Fluctuations: The price of Acetyl Tetrapeptide-3 is influenced by raw material costs for amino acid synthesis, manufacturing complexity, purity requirements, and supplier competition. Pharmaceutical-grade material commands a premium.
• Patent Expiry Impact: As key patents expire, increased competition from generic manufacturers could lead to price erosion, although specialized formulations or proprietary blends may retain higher margins.
• Regulatory Landscape: While primarily used in cosmetics, any classification changes or stricter regulatory oversight in key markets (e.g., EU, US) could impact manufacturing costs and market access.
• Investment Trends: Venture capital and private equity investment in companies developing innovative hair growth solutions and cosmeceutical ingredients are indicative of strong investor confidence in this sector.

Estimated Market Value (Acetyl Tetrapeptide-3 Component):

Given its status as a premium peptide ingredient in a multi-billion dollar global market, the addressable market specifically for Acetyl Tetrapeptide-3, when considered as a raw material commodity, likely falls in the range of tens to low hundreds of millions of dollars annually. This figure is an estimate based on its estimated market share within the broader cosmetic peptide and hair growth ingredient markets. The value is significantly amplified in finished products.

What are the Future Prospects for Acetyl Tetrapeptide-3?

The future prospects for Acetyl Tetrapeptide-3 remain positive, driven by continued demand in its established application areas and potential for expansion into related therapeutic fields.

Continued Dominance in Hair and Lash Enhancement:

The peptide is well-established as an effective ingredient for promoting hair growth and enhancing eyelash density. Consumer awareness and brand adoption are high, ensuring sustained demand. Innovations in topical delivery systems will likely improve its efficacy and expand its use in more sophisticated product formulations.

Potential for Pharmaceutical Expansion:

While its current use is largely cosmetic, the biological mechanisms of Acetyl Tetrapeptide-3, particularly its role in cellular proliferation and extracellular matrix remodeling, suggest potential applications in dermatological indications beyond hair loss.

• Wound Healing: Its ability to stimulate dermal papilla cells and support tissue regeneration could be explored for faster and more effective wound healing formulations.
• Skin Rejuvenation: Similar to other peptides with regenerative properties, Acetyl Tetrapeptide-3 may find applications in anti-aging skincare aimed at improving skin texture and elasticity.
• Scar Treatment: Research into its potential to influence collagen production and tissue repair might lead to applications in scar reduction therapies.

Challenges and Opportunities:

• Competition: The peptide market is competitive, with new peptide sequences and delivery technologies constantly emerging. Manufacturers must focus on cost-effective synthesis, high purity, and robust scientific validation to maintain market share.
• Regulatory Scrutiny: As the line between cosmetics and pharmaceuticals blurs, ingredients like Acetyl Tetrapeptide-3 may face increased regulatory scrutiny, requiring rigorous safety and efficacy data.
• Sustainability: Growing consumer and regulatory emphasis on sustainable sourcing and manufacturing practices will impact raw material production and formulation.

Intellectual Property Strategy:

Manufacturers and formulators will likely continue to pursue patent protection for novel compositions, synergistic combinations with other ingredients, and specific methods of use to secure market advantage and higher profit margins.

Key Takeaways

• Acetyl Tetrapeptide-3 is a synthetic peptide primarily used in topical cosmeceutical products for hair growth and eyelash enhancement, leveraging its ability to stimulate dermal papilla cells.
• The patent landscape is active, covering synthesis, formulations, and methods of use, with significant intellectual property held by cosmetic ingredient developers like Sederma.
• Key market players include raw material manufacturers (e.g., Sederma, DSM) and a wide array of cosmeceutical brands incorporating the peptide into their finished goods.
• The market for Acetyl Tetrapeptide-3 is a component of the larger, multi-billion dollar global cosmetic peptide market, which is experiencing robust growth (6-9% CAGR). Its direct market value is estimated in the tens to low hundreds of millions of dollars annually, with significant value addition in end products.
• Future prospects are strong, driven by sustained demand in hair and lash enhancement and potential expansion into dermatological applications like wound healing and skin rejuvenation.

Frequently Asked Questions

1. What are the primary scientific mechanisms by which Acetyl Tetrapeptide-3 promotes hair growth? Acetyl Tetrapeptide-3 functions by mimicking natural signaling molecules that stimulate dermal papilla cells. This stimulation leads to enhanced hair follicle regeneration, improved blood circulation in the scalp, and strengthened hair anchoring, ultimately promoting hair growth and reducing shedding.

2. How does the cost of Acetyl Tetrapeptide-3 compare to other cosmetic peptides? As a synthetic peptide requiring specialized synthesis and high purity standards for pharmaceutical and cosmeceutical applications, Acetyl Tetrapeptide-3 is generally positioned at a premium price point compared to simpler amino acids or basic peptide chains. Its cost is influenced by manufacturing complexity, purity, and supplier competition, with pharmaceutical-grade material commanding higher prices.

3. Are there any regulatory restrictions on the use of Acetyl Tetrapeptide-3 in different regions? In regions like the European Union and the United States, Acetyl Tetrapeptide-3 is primarily regulated as a cosmetic ingredient. Its use is subject to general cosmetic regulations concerning safety, labeling, and claims. However, ongoing discussions regarding the classification of ingredients at the cosmetic-drug interface may lead to future regulatory considerations. Users should consult specific regional cosmetic regulatory bodies for the most current guidelines.

4. What is the typical shelf life and storage requirement for Acetyl Tetrapeptide-3 raw material? Pharmaceutical-grade Acetyl Tetrapeptide-3 typically has a shelf life of 2 to 3 years when stored under recommended conditions. These conditions usually involve refrigeration (2-8°C) and protection from light and moisture to maintain its stability and purity.

5. Can Acetyl Tetrapeptide-3 be used in conjunction with other hair growth ingredients for synergistic effects? Yes, Acetyl Tetrapeptide-3 is often formulated with other active ingredients to achieve synergistic effects. A prominent example is its combination with Trifolium Pratense (Red Clover) Flower Extract in commercial products, where the peptide and botanical extract are designed to work together to promote hair health. Formulators explore combinations with minoxidil, other peptides, vitamins, and botanical extracts to enhance overall efficacy.

Citations

[1] Grand View Research. (2023). Cosmetic Peptides Market Size, Share & Trends Analysis Report. [2] Mordor Intelligence. (2023). Cosmetic Peptides Market - Growth, Trends, COVID-19 Impact, and Forecasts. [3] Sederma. (n.d.). Capixyl™. Retrieved from Sederma's official website. [4] Various patent databases and scientific literature searches (e.g., USPTO, Espacenet, PubMed).